OTCMKTS:CRLBF

Cresco Labs Stock Forecast, Price & News

$10.54
-0.18 (-1.68 %)
(As of 07/23/2021 08:10 PM ET)
Add
Compare
Today's Range
$10.20
$10.72
50-Day Range
$10.29
$12.25
52-Week Range
$5.05
$17.49
Volume396,300 shs
Average Volume1.03 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive CRLBF News and Ratings via Email

Sign-up to receive the latest news and ratings for Cresco Labs and its competitors with MarketBeat's FREE daily newsletter.


Cresco Labs logo

About Cresco Labs

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; flowers, popcorns, shakes, pre-rolls, and vapes under the High Supply brand; flowers, vapes, and edibles under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, ingestibles, sublingual oils, and transdermal patches under the Remedi brand, as well as cannabis products made from plants under the Reserve brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections, fruit-forward gummies, hard sweets, and taffy under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. It owns and operates 32 dispensaries, as well as 44 retail licenses. The company is headquartered in Chicago, Illinois.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.30 out of 5 stars

Medical Sector

1801st out of 4,434 stocks

Drug Manufacturers - Specialty & Generic Industry

13th out of 120 stocks

Analyst Opinion: 3.5Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Cresco Labs (OTCMKTS:CRLBF) Frequently Asked Questions

Is Cresco Labs a buy right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last year. There are currently 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Cresco Labs stock.
View analyst ratings for Cresco Labs
or view top-rated stocks.

What stocks does MarketBeat like better than Cresco Labs?

Wall Street analysts have given Cresco Labs a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cresco Labs wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Cresco Labs?

Cresco Labs saw a decline in short interest in the month of June. As of June 15th, there was short interest totaling 293,700 shares, a decline of 43.7% from the May 31st total of 521,300 shares. Based on an average daily volume of 1,056,800 shares, the days-to-cover ratio is presently 0.3 days.
View Cresco Labs' Short Interest
.

When is Cresco Labs' next earnings date?

Cresco Labs is scheduled to release its next quarterly earnings announcement on Wednesday, August 18th 2021.
View our earnings forecast for Cresco Labs
.

How has Cresco Labs' stock been impacted by Coronavirus?

Cresco Labs' stock was trading at $3.34 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CRLBF shares have increased by 215.6% and is now trading at $10.54.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for CRLBF?

8 brokerages have issued twelve-month price targets for Cresco Labs' stock. Their forecasts range from $11.00 to $36.00. On average, they anticipate Cresco Labs' stock price to reach $23.28 in the next year. This suggests a possible upside of 120.9% from the stock's current price.
View analysts' price targets for Cresco Labs
or view top-rated stocks among Wall Street analysts.

Who are Cresco Labs' key executives?

Cresco Labs' management team includes the following people:
  • Mr. Charles Bachtell, Co-Founder, CEO & Director (Age 42, Pay $537.5k)
  • Mr. Dennis M. Olis, Chief Financial Officer (Age 58, Pay $202.12k)
  • Mr. Thomas J. Manning, Exec. Chairman (Age 64)
  • Mr. Robert M. Sampson, Co-Founder & Director (Age 46)
  • Mr. Ty Gent, Chief Operating Officer (Age 62)
  • Ms. Brenna Albert CPA, Sr. VP and Controller of Accounting, Treasury & Tax
  • Mr. Mo Dastagir, Chief Information Officer (Age 44)
  • Jake Graves, Mang. of Investor Relations
  • Mr. John Schetz, Gen. Counsel (Age 44)
  • Ms. Impola Kelli, VP of Compliance

Who are some of Cresco Labs' key competitors?

What is Cresco Labs' stock symbol?

Cresco Labs trades on the OTCMKTS under the ticker symbol "CRLBF."

How do I buy shares of Cresco Labs?

Shares of CRLBF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cresco Labs' stock price today?

One share of CRLBF stock can currently be purchased for approximately $10.54.

How many employees does Cresco Labs have?

Cresco Labs employs 2,700 workers across the globe.

What is Cresco Labs' official website?

The official website for Cresco Labs is www.crescolabs.com.

How can I contact Cresco Labs?

The company can be reached via phone at 312-929-0993.


This page was last updated on 7/26/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.